BridgeBio Pharma, Inc.’s Q3 2026 10-Q window runs Oct 26, 2026 to Nov 13, 2026.
Based on 8 prior 10-Q filings.
BridgeBio Pharma, Inc. · CIK 1743881 · Engraved from SEC EDGAR